In addition, a significant positive correlation between the NFkB (RelA) and FAT1 expression was observed in non-glioma tumors like pancreatic cancer (n = 176) cases (r = 0.307, p = 0.00003); hepatocellular cancer (n = 365) cases (r = 0.238, p = 0.000004); stomach cancer (n = 354) cases (r = 0.158, p = 0.003) and lung cancer (n = 994) cases (r = 0.126, p < 0.0001) (Additional file 1: Figure S4). Here, FAT1 is linked to hepatocellular carcinoma.